There is great need for improved understanding of the mechanistic biology underlying Parkinson’s disease. Such knowledge will help with development of new drugs that slow or even halt the progression of the disease. The discovery that hyper-activating mutations in a protein kinase termed LRRK2 causes Parkinson’s, offers the prospect of elaborating new, potentially disease-modifying treatments .
Recruitment for our Wellcome 4-Year PhD Programme in Integrated molecular, cellular and translational biology is now open. Greater than 40 different supervisors participate with diverse research areas. Further information can be found on the programme website. Students on this programme will carry out three short laboratory placements prior to selection of main PhD project.